学术探索
学术期刊
新闻热点
数据分析
智能评审

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

被引：120
作者：
Chapppuis, PO
Goffin, J
Wong, N
Perret, C
Ghadirian, P
Tonin, PN
Foulkes, WD
机构：
[1] McGill Univ, Div Med Genet, Dept Med, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[3] McGill Univ, Sir MB Davis Jewish Gen Hosp, Canc Prevent Res Unit, Montreal, PQ, Canada
[4] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada
[5] McGill Univ, Fac Med, CHUM,Hotel Dieu, Epidemiol Res Unit,Res Ctr, Montreal, PQ, Canada
[6] McGill Univ, Dept Med, Montreal, PQ, Canada
[7] McGill Univ, Ctr Hlth, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada
[8] McGill Univ, Ctr Hlth, Program Canc Genet, Dept Human Genet, Montreal, PQ, Canada
来源：
JOURNAL OF MEDICAL GENETICS | 2002年 / 39卷 / 08期
关键词：
D O I：
10.1136/jmg.39.8.608
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：608 / 610
页数：3
相关论文
共 24 条
  • [1] Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells
    Abbott, DW
    Freeman, ML
    Holt, JT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (13) : 978 - 985
  • [2] The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
    Bhattacharyya, A
    Ear, US
    Koller, BH
    Weichselbaum, RR
    Bishop, DK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 23899 - 23903
  • [3] Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation
    Buchholz, TA
    Tucker, SL
    Masullo, L
    Kuerer, HM
    Erwin, J
    Salas, J
    Frye, D
    Strom, EA
    McNeese, MD
    Perkins, G
    Katz, A
    Singletary, SE
    Hunt, KK
    Buzdar, AU
    Hortobagyi, GN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 17 - 23
  • [4] Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
    Chang, J
    Powles, TJ
    Allred, DC
    Ashey, SE
    Clark, GM
    Makris, A
    Assersohn, L
    Gregory, RK
    Osborne, CK
    Dowsett, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3058 - 3063
  • [5] Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome after breast cancer
    Chappuis, PO
    Kapusta, L
    Bégin, LR
    Wong, N
    Brunet, JS
    Narod, SA
    Slingerland, J
    Foulkes, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) : 4045 - 4052
  • [6] Chappuis PO, 2001, AM J HUM GENET, V69, P249
  • [7] Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    Fisher, B
    Bryant, J
    Wolmark, N
    Mamounas, E
    Brown, A
    Fisher, ER
    Wickerham, DL
    Begovic, M
    DeCillis, A
    Robidoux, A
    Margolese, RG
    Cruz, AB
    Hoehn, JL
    Lees, AW
    Dimitrov, NV
    Bear, HD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2672 - 2685
  • [8] Low expression of bcl-2 in Brca1-associated breast cancers
    Freneaux, P
    Stoppa-Lyonnet, D
    Mouret, E
    Kambouchner, M
    Nicolas, A
    Zafrani, B
    Vincent-Salomon, A
    Fourquet, A
    Magdelenat, H
    Sastre-Garau, X
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (10) : 1318 - 1322
  • [9] Gene-expression profiles in hereditary breast cancer.
    Hedenfalk, I
    Duggan, D
    Chen, YD
    Radmacher, M
    Bittner, M
    Simon, R
    Meltzer, P
    Gusterson, B
    Esteller, M
    Kallioniemi, OP
    Wilfond, B
    Borg, Å
    Trent, J
    Raffeld, M
    Yakhini, Z
    Ben-Dor, A
    Dougherty, E
    Kononen, J
    Bubendorf, L
    Fehrle, W
    Pittaluga, S
    Gruvberger, S
    Loman, N
    Johannsoson, O
    Olsson, H
    Sauter, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) : 539 - 548
  • [10] Husain A, 1998, CANCER RES, V58, P1120
123